Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated commercial biotechnology company, today announced licensing exclusive worldwide rights to TNX-4900 ...

One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in which a patient's own immune system is trained to recognize and attack ...

A hidden “jack-in-the-box” mechanism inside T cells may hold the key to unlocking more powerful cancer immunotherapies.

Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family ...

New research provides evidence that the Alzheimer’s disease drug Lecanemab functions by activating a specific cleaning ...

Citi Annual Global Healthcare Conference 2025 December 3, 2025 4:00 PM ESTCompany ParticipantsMarshall Fordyce - ...

Denali's validated platform, strategic pipeline, and experienced management present a compelling long-term investment opportunity. Find out why DNLI stock is a Buy.

Checkpoint inhibitors have revolutionized cancer treatment by enhancing T-cell responses against tumors, leading to long-term tumor regression. These inhibitors, including anti-PD-1/PD-L1 and ...

Chemerin is a key adipokine that regulates lipid metabolism and insulin sensitivity, and thus is involved in many metabolic diseases such as obesity and diabetes. In addition, it plays a critical role ...

While the COVID pandemic has thankfully been over for some time now, there is still a considerable number of people in the world (about 400 million) suffering from long COVID. Long COVID is a chronic ...

Now researchers from Japan's Okayama University of Science have found another way bitter taste receptors function in cancer cells. They discovered that the receptors, known as TAS2Rs, become activated ...